JP2001200000A - Method for producing collagen derived from marine organism - Google Patents

Method for producing collagen derived from marine organism

Info

Publication number
JP2001200000A
JP2001200000A JP2000014283A JP2000014283A JP2001200000A JP 2001200000 A JP2001200000 A JP 2001200000A JP 2000014283 A JP2000014283 A JP 2000014283A JP 2000014283 A JP2000014283 A JP 2000014283A JP 2001200000 A JP2001200000 A JP 2001200000A
Authority
JP
Japan
Prior art keywords
membrane
collagen
purification
concentration
filtration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000014283A
Other languages
Japanese (ja)
Other versions
JP3532817B2 (en
Inventor
Taketomo Shikahara
健知 鹿原
Satoshi Miyazaki
聡 宮崎
Mina Okamura
美奈 岡村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Air Water Inc
Original Assignee
Air Water Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Air Water Inc filed Critical Air Water Inc
Priority to JP2000014283A priority Critical patent/JP3532817B2/en
Publication of JP2001200000A publication Critical patent/JP2001200000A/en
Application granted granted Critical
Publication of JP3532817B2 publication Critical patent/JP3532817B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To enable the removal of finely divided particles such as coloring matter, the concentration of collagen and the removal of added pepsin or the like and to realize mass production in an inexpensive equipment with pollution of outside excluded by employing and adding new purification and concentration processes because it is clifficult to put the present method for producing collagen from salmon, etc., into practical use due to the thinness of salmon skin leading to the impossibility of physically removing impurity-containing epidermis alone and therefore to both of the impossibility of mass production and the expensiveness of equipment because of finally performing the removal of impurities by an ultracentrifuge. SOLUTION: It is the same way as a conventional one that a preprocessing process for degreasing and cleansing skins of marine organisms is followed by an extracting process for extracting collagen with an organic acid and also making it atheromatous using pepsin, etc. Then, a purified collagen solution is obtained by a purifying process for removing impurities from the crude collagen solution obtained there and for making the solution pass through a purification membrane. The collagen solution is applied with a concentrating process for making it pass through a concentration membrane and is finally applied with a conventional filtration process for sterilization to obtain a product of soluble collagen in enzyme.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は鮭など海洋生物の皮
膚を原料として、各種の医療用生体材料、化粧品材料そ
して食品材料等に有用である酸可溶性コラーゲンの量産
可能な製造方法に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for mass-producing acid-soluble collagen useful for various medical biomaterials, cosmetic materials, food materials, and the like, using the skin of marine organisms such as salmon as a raw material.

【0002】[0002]

【従来の技術】既知の通り上記のコラーゲンは主として
牛や豚などのほ乳類について、その皮膚を原料として抽
出されており、さらに近年上記ほ乳類だけでなく加工処
理後に産業廃棄物となる海洋生物の皮膚からもコラーゲ
ンを抽出製造しようとする研究が行われている。先ず前
者のほ乳類によるコラーゲン製造の方法にあっては、図
6の如くその皮膚層が表皮層aと真皮層bおよび皮下層
cとからなり、表皮層aから真皮層bまでが5〜7mm程
度と可成りの厚さを有すると共に、コラーゲンは真皮層
bに、そして色素等の不純物は表皮層aに夫々含まれて
おり、同図のdは色素細胞を示している。
2. Description of the Related Art As is known, the above collagen is mainly extracted from the skin of mammals such as cows and pigs as a raw material. In recent years, not only the above mammals but also the skin of marine organisms that become industrial waste after processing. Studies have been conducted to extract and produce collagen from corn. First, in the former method of producing collagen using mammals, as shown in FIG. 6, the skin layer is composed of an epidermis layer a, a dermis layer b, and a subcutaneous layer c, and the length from the epidermis layer a to the dermis layer b is about 5 to 7 mm. Collagen is contained in the dermis layer b, and impurities such as pigment are contained in the epidermal layer a, respectively.

【0003】このためほ乳類にあっては前処理工程とし
て、比較的厚手の皮膚から次段の抽出工程に先行して、
その色素等を含む表皮層aを物理的に切離等の手段で除
去するようにしているため、後述する海洋生物の場合に
比し色素等の混入がほとんどないコラーゲンを得ること
が可能である。そして、上記の抽出工程で得られたコラ
ーゲン溶液を遠心分離装置にかけて、さらに不純物を除
去した後に滅菌ろ過工程を経てコラーゲンを製造するよ
うにしており、この際上記の遠心分離装置としても大型
なものが入手できることから一度に大量のコラーゲンを
精製することができ、その量産化が可能となっている。
[0003] For this reason, in mammals, as a pretreatment step, relatively thick skin is preceded by the next extraction step.
Since the epidermis layer a containing the pigment and the like is physically removed by means such as separation, it is possible to obtain collagen with little contamination of the pigment and the like as compared with marine organisms described below. . Then, the collagen solution obtained in the above-mentioned extraction step is subjected to a centrifugal separator, and after removing impurities, a collagen is produced through a sterile filtration step. In this case, the centrifugal separator is also large. As a result, a large amount of collagen can be purified at a time, and its mass production is possible.

【0004】しかし、上記ほ乳類の場合に比し、海洋生
物からのコラーゲン製造手段については、まだ研究途上
にあることから、以下の如き方法が小規模に試行されて
いる段階にある。先ず、鮭等の海洋生物は、その皮膚層
が前掲図6と同じく三層により形成されているが、図7
の通り皮下層cを除く表皮層aから真皮層b間までの厚
さが約1〜2mmであって、ほ乳類の場合に比し非常に薄
く、しかもコラーゲンはもちろん真皮層bに含まれてお
り、しかも色素細胞dは、当該真皮層bの上層部位に存
在し、かつほ乳類に比し当該不純物の量が可成り多い。
However, as compared with the above-mentioned mammals, the means for producing collagen from marine organisms is still in the course of research, so that the following methods are at a stage of trial on a small scale. First, the skin layers of marine organisms such as salmon are formed of three layers as in FIG.
The thickness between the epidermis layer a and the dermis layer b excluding the subcutaneous layer c is about 1 to 2 mm, which is extremely thin compared to mammals, and collagen is of course contained in the dermis layer b. In addition, the pigment cells d are present in the upper layer of the dermis layer b, and the amount of the impurities is considerably larger than that of mammals.

【0005】従って海洋生物の場合にあっては、上記の
通りその皮膚層が薄いことからほ乳類のように色素等を
含んだ部分だけの除去が実際上不能であり、従って第1
の前処理工程では図7の鱗eや身そして、鰭等を除去す
る程度で鮭皮を得、図8に例示する如くこれを細断した
後脂質の抽出、そして洗浄を行うようにし、これにより
得られた処理済サンプルを既知の如く有機酸により処理
してコラーゲンを抽出すると同時にペプシン等を加えて
アテロ化するか、同上図の如く抽出処理後に遠心分離装
置にかけ、その後でアテロ化処理を行う何れかの方法を
選択して第2の抽出工程を実施するようにしている。こ
の結果コラーゲンの抽出後の溶液中には色素等の不純物
が、当然のことながら微粒子となって多数存在すること
となり、しかもこの微粒子は重量が非常に軽いため、前
記した抽出工程における通常の遠心分離処理では沈殿す
ることなく、その除去が充分にできない。
Therefore, in the case of marine organisms, as described above, since the skin layer is thin, it is practically impossible to remove only a portion containing a pigment or the like, such as a mammal.
In the pre-treatment step, salmon skin is obtained to the extent that scale e, body, and fins in FIG. 7 are removed, and as shown in FIG. 8, lipids are extracted and washed, as shown in FIG. The treated sample obtained by the above is treated with an organic acid as is known to extract collagen, and at the same time, pepsin or the like is added to the treated sample, or the extract is subjected to centrifugation after the extraction treatment as shown in the above figure. The second extraction step is performed by selecting one of the methods to be performed. As a result, impurities such as pigments are naturally present in the solution after collagen extraction in the form of fine particles in large numbers.Moreover, since these fine particles are very light in weight, ordinary centrifugation in the above-mentioned extraction step is performed. The separation treatment does not precipitate and cannot be sufficiently removed.

【0006】そこで上記抽出工程で得られた粗コラーゲ
ンを、次の第3である精製工程において、先ず塩析と遠
心分離を繰り返すことにより、塩析で得た沈殿を遠心分
離で回収して、ペプシンの除去と不純物の除去とを行
い、これに酢酸を加えて酸可溶性コラーゲンを得、さら
にこれを超遠心分離装置にかけて、その上清を回収する
ようにしている。そして、上記図8に示す如く最終であ
る第4の滅菌ろ過工程へ移行するが、ここで前工程での
回収上清による濃縮液をろ過滅菌膜に通して滅菌ろ過
し、透過液を脱イオン水により透析するか、この透析を
先行させて滅菌ろ過を後に行うようにし、その後に凍結
乾燥することで酵素可溶性コラーゲンを得るようにして
いる。
[0006] Therefore, the crude collagen obtained in the above extraction step is subjected to salting out and centrifugation in the next third purification step, whereby the precipitate obtained by salting out is recovered by centrifugation. Pepsin is removed and impurities are removed, and acetic acid is added thereto to obtain an acid-soluble collagen, which is further subjected to an ultracentrifugal separator to collect the supernatant. Then, as shown in FIG. 8 described above, the process proceeds to the final fourth sterilization filtration step. Here, the concentrated solution obtained by the recovered supernatant in the previous process is sterilized and filtered through a filtration sterilization membrane, and the permeated solution is deionized. Either dialysis with water or sterilization filtration is performed before this dialysis, and then lyophilization is performed to obtain enzyme-soluble collagen.

【0007】[0007]

【発明が解決しようとする課題】上記した海洋生物由来
コラーゲンの製造方法によるときは、第3の精製工程で
塩析や遠心分離を行うのであるが、当該遠心分離を何回
も繰り返し行うことだけでは、多数存在していた不純物
としての軽い微粒子は可成りの時間をかけても除去しき
れず、その後に超遠心分離相当(100,000×G)
の遠心力を与えて当該微粒子を沈殿させて除去しなけれ
ばならない。ところが、超遠心分離装置としては、一度
に大量の精製が可能なものを得ることができず、一回で
精製できるコラーゲンの量は400cc程度であり、し
かも量産規模分の台数を揃えることは、非常に高価であ
るため設備投資の面からも非合理的と考えられている。
そこで、この解決策として魚皮から色素等の不純物を除
去することの困難性に鑑み、当該コラーゲンの製造に際
しては無色色素の魚皮、特にフラットフィッシュの皮か
らコラーゲンの抽出を行うようにした内容の製造方法
(特許第2722014号)も提案されている。
According to the above-described method for producing marine collagen derived from marine organisms, salting out and centrifugation are performed in the third purification step, but the centrifugation is repeated many times. Then, light fine particles as impurities which existed in large numbers could not be completely removed even after a considerable time, and thereafter, equivalent to ultracentrifugation (100,000 × G).
The microparticles must be settled and removed by applying centrifugal force. However, as an ultracentrifugal separator, it is not possible to obtain a material that can be purified in large quantities at one time, and the amount of collagen that can be purified at one time is about 400 cc. Because it is very expensive, it is considered irrational in terms of capital investment.
In view of the difficulty in removing impurities such as pigments from fish skin as a solution to this problem, in the production of the collagen, collagen is extracted from fish skin of colorless pigments, particularly from flat fish skin. (Japanese Patent No. 2722014) has also been proposed.

【0008】本願発明にあっては、上記従来技術の難点
に鑑み検討されたもので、請求項1によるときは図8に
よりコラーゲンの製造方法に比し、第1、第2の夫々前
処理工程と抽出工程そして最終の滅菌ろ過工程には本質
的な相違はないが、前記第3の精製工程のように遠心分
離や塩析そして超遠心分離処理を行うのではなく、精製
ろ過処理による精製工程と次段の濃縮処理による濃縮工
程を設定するようにして、当該前者の精製ろ過処理によ
って従来の超遠心分離装置を用いることなしに色素等の
微粒子除去を可能となし、上記後者の濃縮工程ではコラ
ーゲンを濃縮すると共に従来遠心分離で除去していたペ
プシンなどの不純物除去をも可能にしようとしている。
このことにより請求項1では上記の精製工程における精
製ろ過処理により抽出工程後の粗コラーゲン溶液から色
素等の不純物の除去を高価な設備なしに連続的に実現可
能とし、必要生産規模に応じたコラーゲンの大量精製を
実現しようとするのが第1の目的である。しかも上記従
来の製造方法に比し製造日程の大幅な短縮を可能とし、
遠心分離と違って閉鎖的な製造ラインが採択できるよう
にし、このことにより外部からの汚染についても心配の
ない衛生面からも安心して製造できるようにするのが第
2の目的であり、かくして産業廃棄物とされている海洋
生物の皮膚から、安価な提供が望まれているコラーゲン
を医療関係、化粧関係、食品関係に提供可能にしようと
している。
The present invention has been studied in view of the above-mentioned disadvantages of the prior art, and the first and second pretreatment steps according to claim 1 are different from the method for producing collagen according to FIG. There is no essential difference between the extraction step and the final sterilization filtration step. However, instead of performing centrifugation, salting out and ultracentrifugation as in the third purification step, a purification step by purification filtration treatment is performed. And by setting the concentration step by the subsequent concentration treatment, it is possible to remove fine particles such as dyes without using a conventional ultracentrifugal separator by the former purification and filtration treatment, in the latter concentration step Attempts are being made to concentrate collagen and to remove impurities such as pepsin, which have conventionally been removed by centrifugation.
According to the first aspect of the present invention, the purification and filtration treatment in the above-mentioned purification step makes it possible to continuously remove impurities such as pigments from the crude collagen solution after the extraction step without using expensive equipment, and the collagen according to the required production scale The first object is to realize a large-scale purification of. Moreover, the production schedule can be significantly shortened compared to the conventional production method described above,
The second purpose is to make it possible to adopt a closed production line unlike centrifugal separation, and to make it possible to manufacture with confidence from the aspect of sanitation without worrying about external contamination. From the skin of marine organisms, which are regarded as waste, we are trying to make collagen, which is desired to be provided at low cost, available to medical, cosmetic, and food industries.

【0009】次に請求項2にあっては、上記した請求項
1における精製工程で抽出工程からの粗コラーゲン溶液
から不要物を除去するための精製膜に関し、その膜サイ
ズを1.0μm未満〜0.1μmとすることで、さらに
コラーゲンの回収率を低下させず、しかも色素の微粒子
除去効率をも低下させることのない、より望ましい精製
効果を発揮させ得るようにするのが第1の目的である。
そして、さらに請求項2では、これまた請求項1におけ
る前掲濃縮工程で、上記精製ろ過工程から精製コラーゲ
ン溶液の分子量分画以下の不純物を除去する濃縮用膜に
関し、その膜サイズを1000K未満〜10Kの限界ろ
過膜とすることで、ペプシン等の不純物除去率の低下と
コラーゲンの回収率低下との回避を両立させて、より望
ましい濃縮効果をあげようとするのが第2の目的であ
る。
In a second aspect, the present invention relates to a purification membrane for removing unnecessary substances from the crude collagen solution from the extraction step in the purification step in the above-mentioned claim 1, wherein the membrane size is less than 1.0 μm. The first object of the present invention is to make it possible to exhibit a more desirable purification effect by further reducing the collagen recovery rate and the pigment fine particle removal efficiency by setting the thickness to 0.1 μm. is there.
According to a second aspect of the present invention, there is provided a concentration membrane for removing impurities having a molecular weight fraction or less of a purified collagen solution from the purification and filtration step in the concentration step of the first aspect of the present invention. It is a second object of the present invention to achieve a more desirable concentration effect by making the ultrafiltration membrane of (1) compatible with a reduction in the removal rate of impurities such as pepsin and a reduction in the recovery rate of collagen.

【0010】請求項3の場合には、上記請求項1と請求
項2とにあって、より望ましい精製効果と濃縮効果につ
き、その信頼性を高めるためには精製膜の膜サイズは
0.2μm〜0.6μm、濃縮用膜の膜サイズは10K
〜100Kと特定するのが、より望ましいことを明示し
ている。
In the case of claim 3, the purifying membrane has a size of 0.2 μm in order to improve the reliability of the purifying effect and the concentrating effect. ~ 0.6 μm, membrane size of concentration membrane is 10K
It specifies that it is more desirable to specify ~ 100K.

【0011】そして請求項4にあっては、上記の請求項
1ないし請求項3にあって、同上精製膜と濃縮用膜とに
対し、夫々粗コラーゲン溶液や精製コラーゲン溶液そし
て濃縮コラーゲン溶液が、その流れ方向と直交するよう
に透過させるようにし、不純物が膜表面に堆積すること
を排除して目詰まりの生じないようにし、最終的に得ら
れる酵素可溶コラーゲンの純度を、より向上させようと
している。
According to a fourth aspect of the present invention, in the first to third aspects, the crude collagen solution, the purified collagen solution, and the concentrated collagen solution are provided with respect to the purified membrane and the concentration membrane, respectively. Permeate perpendicular to the flow direction, eliminate the deposition of impurities on the membrane surface to prevent clogging, and further improve the purity of the finally obtained enzyme-soluble collagen. And

【0012】次に請求項5以降にあっては、上記のもの
が抽出工程にあって抽出とアテロ化を同時に進行させて
抽出されるコラーゲンの量を増加させようとするのに対
して、抽出によって得た粗コラーゲン溶液から不純物を
除去して精製膜を通過させることで精製ろ過を行い、こ
れにより不純物を除去し後にアテロ化を行うようにした
点で相違しており、かくして前記図8の従来例の如く遠
心分離によることなしに、精製ろ過処理をここで採択し
てその後の精製工程における不純物の除去を、より行い
易くしようとしている。
Next, in claim 5 or later, while the above-mentioned one is in the extraction step, the extraction and the atherolation are simultaneously advanced to increase the amount of extracted collagen, 8 in that crude impurities were removed from the crude collagen solution obtained and passed through a purification membrane to carry out purification and filtration, thereby removing impurities and performing atherosylation. Instead of centrifugation as in the conventional example, a purification and filtration treatment is adopted here to make it easier to remove impurities in a subsequent purification step.

【0013】そして請求項6では前記の請求項1に対す
る請求項2のように、請求項5に対して抽出工程と精製
工程では膜サイズ1.0μm未満〜0.1μmの精製
膜、そして濃縮工程では膜サイズが1000K未満10
Kの濃縮用膜を採択して、夫々精製効果と濃縮効果とを
助長しようとしており、請求項7では前記の請求項3と
同様に夫々の膜サイズにつき0.2μm〜0.6μm、
そして10K〜100Kの如くその選択範囲を限定する
ことにより、上記精製効果と濃縮効果の、より望ましい
結果を得ようとしている。また請求項8によるときは、
請求項5ないし請求項7に対して、抽出工程や精製工程
の精製膜、さらには濃縮工程における濃縮用膜には、粗
コラーゲン溶液と第1、第2精製コラーゲン溶液と濃縮
コラーゲン溶液とが、その流れ方向に対して直交するよ
う透過させることで、その不純物除去効率を向上しよう
としている。
According to a sixth aspect of the present invention, as in the second aspect of the first aspect, the extraction step and the purification step of the fifth aspect have a membrane size of less than 1.0 μm to 0.1 μm, and a concentration step. In the film size is less than 1000K10
A membrane for concentration of K is adopted to promote the purification effect and the concentration effect, respectively. In claim 7, 0.2 μm to 0.6 μm for each membrane size as in claim 3 described above,
By limiting the selection range to 10K to 100K, more desirable results of the above-mentioned purification effect and concentration effect are intended to be obtained. In the case of claim 8,
In contrast to Claims 5 to 7, a crude collagen solution, first and second purified collagen solutions, and a concentrated collagen solution are provided in a purification membrane in an extraction step or a purification step, and further in a concentration membrane in a concentration step. An attempt is made to improve the impurity removal efficiency by transmitting light perpendicular to the flow direction.

【0014】[0014]

【課題を解決するための手段】本発明は上記の目的を達
成するため、請求項1にあっては、海洋生物の皮膚を脱
脂した後洗浄して処理済サンプルを得る前処理工程と、
この処理済サンプルに有機酸を加えてコラーゲンを抽出
すると共に、蛋白質分解酵素を加えてアテロ化を行うこ
とにより粗コラーゲン溶液を抽出する抽出工程と、当該
粗コラーゲン溶液から不溶物を除去して精製膜を通過さ
せる精製工程と、これにより得られた精製コラーゲン溶
液を濃縮用膜に通過させることにより濃縮して、分子量
分画以下の不純物を除去するようにした濃縮工程と、こ
れにより得られた濃縮コラーゲン溶液を、透析処理と滅
菌ガスにより加圧することでろ過滅菌膜を通過させる滅
菌ろ過処理の何れかを先行することにより、滅菌ろ過後
サンプルを回収する滅菌ろ過工程とからなることを特徴
とする海洋生物由来コラーゲンの製造方法を提供しよう
とするものである。
According to the present invention, in order to achieve the above object, there is provided a pretreatment step for obtaining a treated sample by degreased and then washed marine skin.
An extraction step of extracting a crude collagen solution by adding an organic acid to the treated sample to extract collagen and adding a proteolytic enzyme to perform atherolation, and purifying by removing insolubles from the crude collagen solution A purification step of passing through a membrane, and a concentration step of concentrating the purified collagen solution obtained by passing the purified collagen solution through a concentration membrane to remove impurities having a molecular weight fraction or less. The concentrated collagen solution is characterized by comprising a sterilization filtration step of recovering a sample after sterilization filtration by preceding any of the sterilization filtration treatment of passing through a filtration sterilization membrane by dialysis treatment and pressurization with sterilization gas. It is an object of the present invention to provide a method for producing marine organism-derived collagen.

【0015】さらに請求項2では、上記請求項1の内容
に付加して、その前処理工程において得られた処理済サ
ンプルに有機酸を加えてコラーゲンを抽出すると共に、
蛋白質分解酵素を加えてアテロ化を行うことにより粗コ
ラーゲン溶液を抽出する抽出工程と、当該粗コラーゲン
溶液から不溶物を除去して膜サイズが1.0μm未満〜
0.1μmである精密ろ過膜による精製膜を通過させる
精製工程と、これにより得られた精製コラーゲン溶液を
膜サイズが1000K未満〜10Kの限外ろ過膜である
濃縮用膜に通過させることにより濃縮して、分子量分画
以下の不純物を除去するようにした濃縮工程と、これに
より得られた濃縮コラーゲン溶液を、透析処理と滅菌ガ
スにより加圧することでろ過滅菌膜を通過させる滅菌ろ
過処理の何れかを先行することにより、滅菌ろ過後サン
プルを回収する滅菌ろ過工程とからなることを、その内
容としている。
According to a second aspect, in addition to the contents of the first aspect, an organic acid is added to the treated sample obtained in the pretreatment step to extract collagen,
An extraction step of extracting a crude collagen solution by adding at least a protease and performing atherolation, and removing an insoluble substance from the crude collagen solution to reduce the membrane size to less than 1.0 μm.
A purification step of passing through a purification membrane using a microfiltration membrane of 0.1 μm, and concentration by passing the purified collagen solution obtained through a purification membrane having a membrane size of less than 1000K to 10K as an ultrafiltration membrane. Then, any of a concentration step for removing impurities having a molecular weight fraction or less, and a sterilization filtration treatment in which the concentrated collagen solution thus obtained is passed through a filtration sterilization membrane by pressurizing with a dialysis treatment and a sterilization gas. By preceding the method, the contents of the method include a sterilizing filtration step of collecting a sample after the sterilizing filtration.

【0016】次いで請求項3では、上記請求項1または
請求項2にあって、精製工程における精製膜と、濃縮工
程における濃縮用膜とが夫々0.2μm〜0.65μ
m、10K〜100Kの膜サイズであることを、その内
容としている。
Next, in claim 3, according to claim 1 or claim 2, the purification membrane in the purification step and the concentration membrane in the concentration step are each 0.2 μm to 0.65 μm.
m, and a film size of 10K to 100K.

【0017】そして請求項4にあっては、請求項1ない
し請求項3において、精製工程における精製膜と濃縮工
程における濃縮用膜には、夫々粗コラーゲン溶液と精製
コラーゲン溶液と濃縮コラーゲン溶液とが、その流れ方
向に対して直交する方向で透過して行くようにしたこと
を、その内容としている。
According to a fourth aspect of the present invention, in the first to third aspects, a crude collagen solution, a purified collagen solution, and a concentrated collagen solution are respectively provided in the purification membrane in the purification step and the concentration membrane in the concentration step. That is, the light is transmitted in a direction orthogonal to the flow direction.

【0018】次いで請求項5によるときは、その抽出工
程だけが、前記の請求項1ないし請求項4と相違し、前
処理工程で得た処理済サンプルに有機酸を加えてコラー
ゲンを抽出して得た粗コラーゲン溶液から不溶物を除去
して精製膜を通過させることで精製ろ過し、次いで蛋白
質分解酵素を加えてアテロ化を行うようにしている。
Next, according to the fifth aspect, only the extraction step is different from the first to fourth aspects, and collagen is extracted by adding an organic acid to the treated sample obtained in the pretreatment step. Insoluble matter is removed from the obtained crude collagen solution, and the crude collagen solution is purified by filtration through a purification membrane, and then a proteolytic enzyme is added to perform atherolation.

【0019】また請求項6では、請求項5の構成要件に
対し、抽出工程にあって膜サイズが1.0μm未満〜
0.1μmである精密ろ過膜による精製膜を通過させて
精製ろ過すると共に、膜サイズが1000K未満〜10
Kの限外ろ過膜である濃縮用膜を通過させることにより
濃縮させるようにした内容を付加している。
According to a sixth aspect of the present invention, in the extraction step, the film size is less than 1.0 μm.
Purification and filtration through a purification membrane with a microfiltration membrane of 0.1 μm and a membrane size of less than 1000K to 10
The content added is such that it is concentrated by passing through a concentration membrane which is an ultrafiltration membrane of K.

【0020】そして請求項7では、上記請求項6におけ
る両膜サイズの範囲を、さらに減縮して精製膜とろ過滅
菌膜につき夫々0.2μm〜0.65μm、10K〜1
00Kとしている。
In claim 7, the range of both membrane sizes in claim 6 is further reduced to 0.2 μm to 0.65 μm and 10 K to 1 μm respectively for the purified membrane and the filter sterilized membrane.
00K.

【0021】請求項8にあっては、前記の請求項5〜請
求項7において、抽出工程における精製膜は、その粗コ
ラーゲン溶液がその流れ方向に対して平行する方向で透
過して行き、精製工程における精製膜と濃縮工程におけ
る濃縮用膜には、夫々粗コラーゲン溶液と第1、第2精
製コラーゲン溶液と濃縮コラーゲン溶液とが、その流れ
方向に対して直交する方向で透過して行くようにしたこ
とを、その内容としている。
According to the present invention, the crude membrane in the extraction step permeates the crude collagen solution in a direction parallel to the flow direction, and the purified membrane in the extraction step is subjected to purification. The crude collagen solution, the first and second purified collagen solutions, and the concentrated collagen solution pass through the purification membrane in the step and the concentration membrane in the concentration step, respectively, in a direction perpendicular to the flow direction. That is what it does.

【0022】[0022]

【発明の実施の形態】本発明の請求項1ないし請求項4
に係るコラーゲンの製造方法について図1、図2そして
図4と図5を参照して以下説示すると、請求項1では第
1の前処理工程と第2の抽出工程と第3の精製工程そし
て第4の濃縮工程および第5の滅菌ろ過工程とからなっ
ている。第1の前処理工程では、従前の実施内容と同じ
く鮭皮等の魚皮を流水中で前説の如く身などの不要部を
除去して3cm角程度に細断し、例えばクロロホルムと
メタノールの混合溶液にミンチ済魚皮を投入して攪拌
し、当該溶媒を交換して再攪拌を繰り返した後、メタノ
ールに置換そして脱イオン水に置換して洗浄後、さらに
20%NaClを含んだ緩衝溶液等による洗浄そして脱
イオン水による洗浄を、洗浄液の交換により繰り返して
中性蛋白質を除去することで図1に示す処理済サンプル
を得る。
DESCRIPTION OF THE PREFERRED EMBODIMENTS Claims 1 to 4 of the present invention
The method for producing collagen according to the present invention will be described below with reference to FIGS. 1, 2, 4, and 5. In claim 1, a first pretreatment step, a second extraction step, a third purification step, and a 4 and a fifth sterilization filtration step. In the first pretreatment step, as in the previous practice, fish skin such as salmon skin is cut into approximately 3 cm squares under running water by removing unnecessary parts such as body as described above, for example, mixing chloroform and methanol. The minced fish skin is put into the solution and stirred, the solvent is exchanged, and the mixture is repeatedly stirred, then replaced with methanol, replaced with deionized water, washed, and further, a buffer solution containing 20% NaCl, etc. Washing with deionized water and washing with deionized water are repeated by exchanging the washing solution to remove the neutral protein, thereby obtaining the treated sample shown in FIG.

【0023】第2の抽出工程に関しても、その内容はサ
ンプルを投入した図2の製造装置における抽出タンク1
a、1bに、0,5M酢酸と対基質重量の1%のペプシ
ン、あるいはその他の蛋白質分解酵素を加えて攪拌する
ことで既知の如くアテロ化を行う。このように上記有機
酸によるコラーゲンの抽出と同時にアテロ化を行うよう
にして粗コラーゲン溶液を得るようにすれば、抽出され
るコラーゲンの量が増加する利点があるけれど、同時に
色素等の不純物も大量に溶液中へ混入してくることにな
ることも知られている。
The contents of the second extraction step are the same as those of the extraction tank 1 in the manufacturing apparatus shown in FIG.
Athelation is carried out by adding 0.5M acetic acid and 1% of pepsin or other proteolytic enzyme to the weight of the substrate relative to a and 1b and stirring the mixture as is known. If a crude collagen solution is obtained by performing atherosimilation simultaneously with the extraction of collagen by the organic acid as described above, there is an advantage that the amount of extracted collagen is increased, but at the same time, impurities such as pigments are also large. It is also known that they will be mixed into the solution.

【0024】このようにして得られた粗コラーゲンS1
は、ナイロンメッシュなどを用いて不溶物を除去した
後、図2のポンプ2a、2bを稼動させることによりサ
ンプルタンク3に移し、ここで新規な第3の精製工程を
実施することになる。すなわち、サンプルタンク3の粗
コラーゲンS1はポンプ3a、3bを用いて流速を制御
させながら精製膜4を通過させた後、ここで得られた精
製コラーゲン溶液S2は精製・濃縮タンク5に移送され
る。そして図示例では、精製膜4によって通過を阻止さ
れた残留物等が、サンプル循環流路6を介して前記のサ
ンプタンク3に戻り、またコラーゲンの回収量の増量化
を図るため、溶媒添加用タンク7から溶媒添加流路8を
介してポンプ9により、前記した酢酸等による溶媒を、
サンプルタンク3へ流送添加することで、当該残留物等
に含まれるコラーゲン分子を、さらに回収しようとして
いる。
The thus obtained crude collagen S1
After removing insolubles using a nylon mesh or the like, the pumps 2a and 2b in FIG. 2 are operated to transfer the sample to the sample tank 3, where a new third purification step is performed. That is, after the crude collagen S1 in the sample tank 3 is passed through the purification membrane 4 while controlling the flow rate using the pumps 3a and 3b, the purified collagen solution S2 obtained here is transferred to the purification / concentration tank 5. . In the illustrated example, the residue and the like that have been blocked by the purification membrane 4 return to the sump tank 3 through the sample circulation channel 6 and increase the amount of collagen recovered. The solvent such as acetic acid described above is removed from the tank 7 by the pump 9 through the solvent addition flow path 8,
By flowing the sample to the sample tank 3, the collagen molecules contained in the residue and the like are to be further recovered.

【0025】次に実施される第4の濃縮工程にあって
は、上記した図2の精製・濃縮タンク5に入った精製コ
ラーゲン溶液S2を、ポンプ10により流速等を制御し
ながら濃縮用膜11を通過させた後、同上精製・濃縮タ
ンク5へサンプル循環流路12を介して戻すことにより
濃縮されることになり、この際生じた不溶物は溶媒と共
に排水流路13から廃液タンク14へ排出され、かくし
て当該濃縮工程により、液量の増えた精製コラーゲン溶
液S2の濃縮と、分子量分画以下の不純物の除去がなさ
れることで濃縮コラーゲン溶液S3を得る。
In the fourth concentration step to be carried out next, the purified collagen solution S2 contained in the purification / concentration tank 5 shown in FIG. After being passed through the sample circulation channel 12 to the purification / concentration tank 5 in the same manner as above, the insoluble matter generated at this time is discharged from the drainage channel 13 to the waste liquid tank 14 together with the solvent. Thus, in the concentration step, the purified collagen solution S2 having an increased liquid volume is concentrated and impurities having a molecular weight fraction or less are removed to obtain a concentrated collagen solution S3.

【0026】さらに実施される第5の滅菌ろ過工程は、
図1に示されている通り前記従来のそれと実質的に同じ
内容であり、前記した精製・濃縮タンク5に得られた濃
縮コラーゲン溶液S3を、ポンプ15によって濃縮サン
プル流路16から、ろ過滅菌用タンク17へと送流し
て、全量の送液が終わったならば加圧用気体流路18か
らの滅菌空気とか滅菌窒素ガスによる加圧ガス19によ
って、ろ過滅菌膜20としての膜サイズが例えば0.2
2μmといったものを用いてこれを通過させ、このこと
で製品としてのろ過滅菌後サンプルS4を回収したり、
これを凍結乾燥機21に送って製品とし、かくして酵素
可溶コラーゲンを得るのである。もちろん、この間既知
の如く全工程にわたって温度制御を行い10℃以下好ま
しくは4℃〜5℃程度に保持するのがよく、これは蛋白
質の変性を防止するためである。
The fifth sterilization filtration step to be further performed is:
As shown in FIG. 1, the concentrated collagen solution S3 obtained in the purification / concentration tank 5 is filtered from a concentrated sample flow path 16 by a pump 15 for filtration and sterilization. After the solution is sent to the tank 17 and the entire amount of the solution has been sent, the membrane size of the filtration sterilization membrane 20 is reduced to, for example, 0. 0 by the pressurized gas 19 using sterilized air or sterilized nitrogen gas from the pressurized gas flow path 18. 2
This is passed through using a material such as 2 μm, whereby the sample S4 is collected after filtration and sterilization as a product,
This is sent to the lyophilizer 21 to produce a product, and thus an enzyme-soluble collagen is obtained. Of course, during this time, it is preferable to control the temperature throughout the entire process and maintain the temperature at 10 ° C. or lower, preferably at about 4 ° C. to 5 ° C., in order to prevent denaturation of the protein.

【0027】なおここで因みに前記精製工程にあって
は、予め精製膜4の洗浄、フラッシング、初期清水透過
流速の確認を行い、上記フラッシング後、必要があれば
バッファー等で系内を最適化するのがよい。また適宜原
液に対して溶媒等を加水することが望ましく、経時的に
圧力や温度を設定し、十分量の透過液が得られたらポン
プ3bを停止し、透過側系内の清澄液を極力回収する。
また、これまた因みに濃縮手順としても、前記の濃縮用
膜11について前同洗浄、フラッシング、初期清水透過
流速の確認そして必要なるバッファー等で系内を最適化
するのがよく、濃縮は必要に応じた濃縮倍率で行うのが
よい。
In this connection, in the purification step, the purification membrane 4 is washed, flushed, and the initial fresh water permeation flow rate is checked in advance. After the flushing, if necessary, the system is optimized with a buffer or the like. Is good. Further, it is desirable to add a solvent or the like to the stock solution as appropriate. The pressure and temperature are set over time, and when a sufficient amount of permeate is obtained, the pump 3b is stopped, and the clarified solution in the permeate side system is recovered as much as possible. I do.
As a concentration procedure, it is preferable to optimize the inside of the system for the concentration membrane 11 with the same washing, flushing, confirmation of the initial fresh water permeation flow rate, and necessary buffers and the like. It is preferable to carry out the concentration at a higher concentration.

【0028】次に請求項2について以下詳記すると、こ
こでは請求項1に説示の抽出工程後に実施される精製工
程にあって用いられる精密ろ過(MF)膜としての精製
膜4と、これに続いて実施の濃縮工程で用いられる濃縮
用膜11とについて、その各膜サイズを特定範囲内に選
定するようにしている。先ず精製膜4の膜サイズについ
ては、1.0μm未満〜0.1μmとするのが好まし
い。すなわち1.0μm以上の膜サイズにすると色素の
微粒子除去が困難になってくることになり、一方膜サイ
ズが0.1μmよりも小さくなると、コラーゲンの回収
率が低下して来ることを確認することができた。そして
濃縮用膜11については、分子量分画が1000K未満
〜10Kの限外ろ過(UF)膜を使用するのが好まし
い。すなわち1000K以上の場合にはコラーゲンの回
収が低下してしまうことになり、一方10Kよりも小さ
くなるとペプシン等の不純物除去率が低下してしまうの
である。
Next, claim 2 will be described in detail. Here, a purification membrane 4 as a microfiltration (MF) membrane used in a purification step performed after the extraction step described in claim 1, Subsequently, with respect to the concentration membrane 11 used in the enrichment step, the respective membrane sizes are selected within a specific range. First, the membrane size of the purification membrane 4 is preferably less than 1.0 μm to 0.1 μm. That is, if the membrane size is 1.0 μm or more, it becomes difficult to remove the fine particles of the dye, while if the membrane size is smaller than 0.1 μm, it is confirmed that the collagen recovery rate decreases. Was completed. For the concentration membrane 11, it is preferable to use an ultrafiltration (UF) membrane having a molecular weight fraction of less than 1000K to 10K. That is, when the temperature is higher than 1000K, the recovery of collagen is reduced. On the other hand, when the temperature is lower than 10K, the removal rate of impurities such as pepsin decreases.

【0029】さらに請求項3によるときは、上記の請求
項1または請求項2において、その精製膜4と濃縮用膜
11の膜サイズにつき、さらに望ましい寸法範囲を選定
するようにしており、精製膜については0.2μm〜
0.65μmにすれば、0.65μm以下とすることに
よって色素の微粒子除去率を低下させず、しかも0.2
μm以上とすることによってコラーゲンの回収率をも低
下させないことを保証することができた。また濃縮用膜
11にあっては、10K〜100Kの膜サイズとするこ
とで、ペプシン等の不純物除去率を低下させず、かつコ
ラーゲンの回収率をも低下させないことを保証すること
ができた。
According to the third aspect, in the first or second aspect, a more desirable dimensional range is selected for the membrane size of the purification membrane 4 and the concentration membrane 11. About 0.2 μm
When the thickness is 0.65 μm, by setting the thickness to 0.65 μm or less, the fine particle removal rate of the dye is not reduced.
By setting it to be not less than μm, it was possible to guarantee that the recovery rate of collagen was not reduced. In addition, in the case of the concentration membrane 11, by setting the membrane size to 10K to 100K, it was possible to guarantee that the rate of removing impurities such as pepsin and the like and the rate of collecting collagen were not reduced.

【0030】さて請求項4にあっては、上記の請求項1
ないし請求項3において用いた精製ろ過工程の精製膜4
と濃縮工程の濃縮用膜11につき、その何れについても
タンジェンシャル・フロー・フィルトレーション(TF
F)を用いるようにするのである。通常多用の膜種で
は、図4の如く膜F1と、これに対する透過溶液の流れ
方向D1とが直交状態となるようにし、従って当該流れ
方向D1と平行する方向で透過して透過側P1に流出す
ることになるが、上記のTFFでは図5のように粗コラ
ーゲン溶液S1や精製コラーゲン溶液S2の透過溶液
が、その流れ方向D2に対して直交する方向へ、精製膜
4や濃縮用膜11である一対の膜F2を夫々透過し、夫
々の透過側P2、P3へ流出することになる。従ってT
FFを用いることで、膜F2の膜面に対する不純物等の
堆積が透過溶液の流動によって防止され、目詰りのない
透過状態を保持することができる。この結果請求項4に
よるときは、その精製ろ過処理と濃縮処理とを極めて短
期日内に処理することができると共に、コラーゲンの回
収率と色素の微粒子やペプシン等の不純物除去率を向上
させることが可能となる。
In claim 4, the above-mentioned claim 1 is described.
And a purification membrane 4 used in the purification filtration step used in claim 3.
And the concentration membrane 11 in the concentration step, both of which are tangential flow filtration (TF
F) is used. In general, the membrane type which is frequently used is such that the membrane F1 and the flow direction D1 of the permeate solution are orthogonal to each other as shown in FIG. However, in the above-mentioned TFF, as shown in FIG. 5, the permeated solution of the crude collagen solution S1 or the purified collagen solution S2 is passed through the purification membrane 4 or the concentration membrane 11 in a direction orthogonal to the flow direction D2. The light passes through a certain pair of films F2, and flows out to the respective transmission sides P2 and P3. Therefore T
By using the FF, accumulation of impurities and the like on the film surface of the film F2 is prevented by the flow of the permeation solution, and a permeation state without clogging can be maintained. As a result, according to claim 4, the purification filtration treatment and the concentration treatment can be performed within a very short period of time, and the recovery rate of collagen and the removal rate of impurities such as pigment fine particles and pepsin can be improved. Becomes

【0031】次に請求項5以降につき詳記すると、先ず
請求項5では前説の請求項1に対して以下の相違点を有
している。すなわち、図1に示されている通りその抽出
工程に関し、抽出処理とアテロ化処理が前記の如く同時
に行われるのではなく、各別に実施されるのであり、こ
の場合は図3に示す如き製造装置によって実施すること
ができる。ここで図3の製造装置が図2のそれと相違す
るところは、前記したサンプルタンク3と精製・濃縮タ
ンク5とが、ポンプ22を介接した第1精製サンプル流
路23によって連通されていることであり、もちろん図
2と同一の部材についてはは同一符号が付されている。
Next, a detailed description will be given of claim 5 and thereafter. First, claim 5 has the following differences from claim 1 described above. That is, as shown in FIG. 1, regarding the extraction step, the extraction processing and the atherification processing are not performed simultaneously as described above, but are performed separately. In this case, the manufacturing apparatus as shown in FIG. Can be implemented. Here, the difference between the manufacturing apparatus of FIG. 3 and that of FIG. 2 is that the sample tank 3 and the purification / concentration tank 5 are communicated with each other by a first purified sample flow path 23 connected with a pump 22. Of course, the same members as those in FIG. 2 are denoted by the same reference numerals.

【0032】さて、同上製造装置を用いて請求項5を実
施するに際し、請求項1と相違するその抽出工程を実施
するには、前同様にして前処理工程により得られた処理
済サンプルS1を抽出タンク1aにあって有機酸を加え
てコラーゲンを押出して得た粗コラーゲン溶液S1を、
ポンプ2aでサンプルタンク3に投入する。そしてこれ
また図2と同様にしてポンプ3aとポンプ3bにより流
速等をコントロールしながら、精製膜4を通過させて第
1精製コラーゲンS5を、精製・濃縮コラーゲン5に流
入させる。これまた前同様にして残留物はサンプル循環
流路6を介してサンプルタンク3に帰還する。また回収
量を増やすため一定量の溶媒を、溶媒添加用タンク7か
ら溶媒添加流路8よりサンプルタンク3へ加える。次い
で当該請求項5にあっては、前記精製・濃縮タンク5の
第1精製コラーゲン溶液S5を、前説の第1精製サンプ
ル流路23を介して、ポンプ22によりサンプルタンク
3へ戻し、ここでペプシン等を加えることでアテロ化処
理を行うのである。かくしてアテロ化されたものを、次
段の精製工程により精製ろ過処理を行うが、当該実施態
様では再び前記の通り精製膜4を介して繰り返しの精製
を行い、これにより得られた第2精製コラーゲン溶液S
6が、前記の精製・濃縮タンク5に流入されることにな
る。そして以後は濃縮工程と滅菌ろ過工程を経て前記の
請求項1と同様にして第2ろ過滅菌後サンプルS7を回
収するのである。
In carrying out claim 5 using the same manufacturing apparatus, in order to carry out the extraction step different from claim 1, the processed sample S1 obtained by the pretreatment step in the same manner as before is used. The crude collagen solution S1 obtained by extruding collagen by adding an organic acid in the extraction tank 1a is
It is put into the sample tank 3 by the pump 2a. The first purified collagen S5 is passed through the purification membrane 4 and flows into the purified / concentrated collagen 5 while controlling the flow rate and the like by the pumps 3a and 3b in the same manner as in FIG. The residue returns to the sample tank 3 via the sample circulation channel 6 in the same manner as before. In order to increase the recovery amount, a certain amount of solvent is added from the solvent addition tank 7 to the sample tank 3 through the solvent addition channel 8. Next, in claim 5, the first purified collagen solution S5 in the purification / concentration tank 5 is returned to the sample tank 3 by the pump 22 via the first purified sample channel 23 described above, and the pepsin By adding the above, the atheromatization process is performed. The atherosylated product is subjected to a purification and filtration treatment in the next purification step. In this embodiment, the purification is repeated again through the purification membrane 4 as described above, and the second purified collagen thus obtained is obtained. Solution S
6 flows into the purification / concentration tank 5 described above. Thereafter, the sample S7 after the second filtration sterilization is recovered in the same manner as in the above-mentioned claim 1 through the concentration step and the sterilization filtration step.

【0033】次に請求項6では、前記請求項1に対する
請求項2のように、請求項5における抽出工程における
精製膜の膜サイズを1.0μm未満〜0.1μmに、そ
して精製工程の精製膜と濃縮工程における濃縮用膜の膜
サイズを1000K未満〜10Kに特定することで、コ
ラーゲンの回収量を確保することと、色素等不純物の除
去とを両立させようとしている。
Next, in claim 6, as in claim 2 with respect to claim 1, the membrane size of the purification membrane in the extraction step in claim 5 is less than 1.0 μm to 0.1 μm, and the purification step is carried out. By specifying the membrane size of the membrane and the membrane for concentration in the concentration step to be less than 1000 K to 10 K, it is intended to ensure both the collection of collagen and the removal of impurities such as dyes.

【0034】さらに、請求項7では請求項1に対する請
求項3のように、上記した膜サイズの特定値を限縮し
て、夫々0.2μm〜0.65μm、10K〜100K
とすることで、より望ましい結果を得るようにしてい
る。
Further, in the seventh aspect, as in the third aspect of the invention, the specific value of the film size is limited to 0.2 μm to 0.65 μm and 10 K to 100 K, respectively.
By doing so, more desirable results are obtained.

【0035】そして請求項8にあっては、請求項1に対
する請求項4と同様にして抽出工程の精製膜では通常の
ろ過膜を用いるが、精製工程の精製膜と濃縮工程の濃縮
用膜については、前説したタンジェンシャル・フロー・
フィルトレーション(TFF)を用いることで、不純物
の除去作用につきその信頼性を持続させようとしてい
る。
According to the eighth aspect, a normal filtration membrane is used for the purification membrane in the extraction step in the same manner as in the fourth aspect of the invention, but the purification membrane in the purification step and the membrane for concentration in the concentration step are used. Is the tangential flow
By using filtration (TFF), the reliability of the action of removing impurities is to be maintained.

【0036】[0036]

【発明の効果】本発明は以上のようにして実施し得るも
のであるから、請求項1によるときは、従来の製法では
抽出工程後における精製工程にあって色素細胞等の不純
物を除去するのに、遠心分離や塩析では、その目的を達
成し得ず、さらに超遠心分離に頼るようにしていたた
め、量産不能にして極めて高価につくことに鑑み、かか
る精製工程を廃し、精製ろ過処理による精製工程に次い
で、濃縮工程を実施するようにしたので、色素等の不純
物除去を高価な設備なしで生産規模に応じたコラーゲン
の大量精製を実現でき、コラーゲンに対する社会的な要
請を充足することが可能となる。さらに請求項1による
ときは、前記従来の製造方法に比しその製造日数を大幅
に短縮することが確認された。すなわち、具体的な比較
例を示すと、従来前の精製工程における遠心分離と塩析
は2〜3回繰り返し実施され、これには10〜20日を
要していたものが、本発明に係る新規な精製ろ過工程と
これに引き続き実施される濃縮工程を1〜2日で完了す
ることが可能となり、しかも当該両工程は前記従来の遠
心分離とか超遠心分離と違って、閉鎖的な製造ラインを
採択できることとなるので、外部汚染の心配がなく、衛
生的な面からも安心して製造することが可能となる。
Since the present invention can be carried out as described above, according to the first aspect, in the conventional production method, impurities such as pigment cells are removed in the purification step after the extraction step. In addition, centrifugal separation and salting-out cannot achieve the purpose and further rely on ultracentrifugation. Since the concentration step is performed after the purification step, large-scale purification of collagen according to the production scale can be realized without expensive equipment for removing impurities such as dyes, thereby satisfying social demands for collagen. It becomes possible. Further, according to the first aspect, it has been confirmed that the number of manufacturing days is significantly reduced as compared with the conventional manufacturing method. That is, when a specific comparative example is shown, centrifugation and salting out in a conventional purification step are repeatedly performed two to three times, which requires 10 to 20 days. A new purification filtration step and a subsequent concentration step can be completed in 1 to 2 days, and both steps are different from the conventional centrifugation or ultracentrifugation in a closed production line. Therefore, there is no need to worry about external contamination, and it is possible to manufacture the apparatus safely from a sanitary point of view.

【0037】請求項2にあっては、上記の両工程におけ
る夫々の精製膜と濃縮用膜の各両膜サイズを夫々特定す
ることで、夫々コラーゲンの回収率と色素の除去効率の
両立と、コラーゲンの回収率とペプシン等の不純物除去
率との望ましい両立を可能とすることができる。さらに
請求項3にあっては、上記請求項2における膜サイズの
範囲を限定することで、請求項2による効果をさらに助
長することが可能となり、請求項4では精製膜と濃縮用
膜について、通常のろ過膜を使用するのでなく、前記T
FFを採択することでコラーゲンに係る最終製品の純度
を、より向上させることが可能となる。
According to the second aspect of the present invention, the size of each of the purification membrane and the membrane for concentration in each of the above two steps is specified, thereby achieving both the recovery rate of collagen and the efficiency of removing pigment. Desirable compatibility between the recovery rate of collagen and the removal rate of impurities such as pepsin can be achieved. Further, in claim 3, by limiting the range of the membrane size in claim 2, it is possible to further promote the effect of claim 2, and in claim 4, the purification membrane and the concentration membrane are: Instead of using a normal filtration membrane, the T
By adopting FF, it becomes possible to further improve the purity of the final product relating to collagen.

【0038】次に請求項5にあっては、従来の製法でも
実施されている抽出工程で、抽出とアテロ化との各処理
間に遠心分離処理を施すようにしていたのに対し、当該
遠心分離処理を廃して、精製ろ過処理を行うことにより
第1精製コラーゲン溶液を得るようにしたので、その続
行工程である精製工程と濃縮工程以前における当該精製
ろ過処理にあって、コラーゲンに対する不純物の除去が
行われることから、精製をより行い易く純度の高いコラ
ーゲンの製造に益すること大である。そして請求項6、
7、8については、上記した請求項1に対する夫々請求
項2、3、4と同様の付加的効果を発揮し得ることとな
るので、その詳細については前説の該当内容を援用す
る。
Next, in the fifth aspect, in the extraction step which is also performed in the conventional production method, centrifugal separation is performed between each of the extraction and the atherolation. Since the first purified collagen solution was obtained by abolishing the separation process and performing the purification and filtration process, the impurities were removed from the collagen in the purification process and the purification and filtration process before the concentration process. Therefore, purification is easier and purification of collagen with high purity is greatly beneficial. And claim 6,
As for the items 7 and 8, the same additional effects as those of the above-mentioned claims 1 to 3 and 4 can be exerted, and the details described in the above description are used.

【図面の簡単な説明】[Brief description of the drawings]

【図1】本発明に係る請求項1と請求項5に係る海洋生
物由来コラーゲンの製造方法を示す工程説明図である。
FIG. 1 is a process explanatory diagram showing a method for producing marine organism-derived collagen according to claims 1 and 5 of the present invention.

【図2】請求項1に係る製造方法を実施することのでき
る製造装置の一例を示した装置系統図である。
FIG. 2 is an apparatus system diagram showing an example of a manufacturing apparatus capable of implementing the manufacturing method according to claim 1;

【図3】請求項5に係る製造方法を実施するのに用い得
る製造装置の一例を示した装置系統図である。
FIG. 3 is an apparatus system diagram showing an example of a manufacturing apparatus that can be used to carry out the manufacturing method according to claim 5;

【図4】不純物除去に用いられる汎用精製膜を示す作用
説明図である。
FIG. 4 is an operation explanatory view showing a general-purpose purification film used for removing impurities.

【図5】不純物除去に用いられるタンジェンシャル・フ
ロー・フィルトレーション(TFF)を示した作用説明
図である。
FIG. 5 is an operation explanatory diagram showing a tangential flow filtration (TFF) used for removing impurities.

【図6】ほ乳類の皮膚層を示す縦断説明図である。FIG. 6 is a longitudinal sectional view showing a mammalian skin layer.

【図7】海洋生物の皮膚層を示す縦断説明図である。FIG. 7 is a longitudinal sectional view showing a skin layer of a marine organism.

【図8】従来の海洋生物由来コラーゲン製造の方法を示
した工程説明図である。
FIG. 8 is a process explanatory view showing a conventional method for producing collagen derived from marine organisms.

【符号の説明】[Explanation of symbols]

4 精製膜 11 濃縮用膜 20 ろ過滅菌膜 S1 粗コラーゲン溶液 S2 精製コラーゲン溶液 S3 濃縮コラーゲン溶液 S4 滅菌ろ過後サンプル S5 第1精製コラーゲン溶液 S6 第2精製コラーゲン溶液 S7 滅菌ろ過後サンプル 4 Purification membrane 11 Concentration membrane 20 Filtration sterilization membrane S1 Crude collagen solution S2 Purified collagen solution S3 Concentrated collagen solution S4 Sample after sterile filtration S5 First purified collagen solution S6 Second purified collagen solution S7 Sample after sterile filtration

───────────────────────────────────────────────────── フロントページの続き (72)発明者 岡村 美奈 北海道千歳市泉沢1007番地 大同ほくさん 株式会社千歳研究センター内 Fターム(参考) 4H045 AA20 CA52 EA01 EA15 EA34 FA16 FA70 GA01 GA10  ──────────────────────────────────────────────────続 き Continued on the front page (72) Inventor Mina Okamura 1007 Izumizawa, Chitose-shi, Hokkaido Daido Hoku Chitose Research Center Co., Ltd. F-term (reference) 4H045 AA20 CA52 EA01 EA15 EA34 FA16 FA70 GA01 GA10

Claims (8)

【特許請求の範囲】[Claims] 【請求項1】 海洋生物の皮膚を脱脂した後洗浄して処
理済サンプルを得る前処理工程と、この処理済サンプル
に有機酸を加えてコラーゲンを抽出すると共に、蛋白質
分解酵素を加えてアテロ化を行うことにより粗コラーゲ
ン溶液を抽出する抽出工程と、当該粗コラーゲン溶液か
ら不溶物を除去して精製膜を通過させる精製工程と、こ
れにより得られた精製コラーゲン溶液を濃縮用膜に通過
させることにより濃縮して、分子量分画以下の不純物を
除去するようにした濃縮工程と、これにより得られた濃
縮コラーゲン溶液を、透析処理と滅菌ガスにより加圧す
ることでろ過滅菌膜を通過させる滅菌ろ過処理の何れか
を先行することにより、滅菌ろ過後サンプルを回収する
滅菌ろ過工程とからなることを特徴とする海洋生物由来
コラーゲンの製造方法。
1. A pretreatment step of obtaining a treated sample by delipidating and washing the skin of a marine organism to obtain a treated sample, adding an organic acid to the treated sample to extract collagen, and adding a proteolytic enzyme to atherotrate. Performing an extraction step of extracting a crude collagen solution, a purification step of removing insolubles from the crude collagen solution and passing through a purification membrane, and passing the purified collagen solution obtained thereby through a concentration membrane. A concentration step of removing the impurities having a molecular weight fraction or less, and a sterilization filtration treatment in which the concentrated collagen solution thus obtained is passed through a filtration sterilization membrane by dialysis treatment and pressurization with a sterilization gas. A method for producing a collagen derived from a marine organism, which comprises: Law.
【請求項2】 海洋生物の皮膚を脱脂した後洗浄して処
理済サンプルを得る前処理工程と、この処理済サンプル
に有機酸を加えてコラーゲンを抽出すると共に、蛋白質
分解酵素を加えてアテロ化を行うことにより粗コラーゲ
ン溶液を抽出する抽出工程と、当該粗コラーゲン溶液か
ら不溶物を除去して膜サイズが1.0μm未満〜0.1
μmである精密ろ過膜による精製膜を通過させる精製工
程と、これにより得られた精製コラーゲン溶液を膜サイ
ズが1000K未満〜10Kの限外ろ過膜である濃縮用
膜に通過させることにより濃縮して、分子量分画以下の
不純物を除去するようにした濃縮工程と、これにより得
られた濃縮コラーゲン溶液を、透析処理と滅菌ガスによ
り加圧することでろ過滅菌膜を通過させる滅菌ろ過処理
の何れかを先行することにより、滅菌ろ過後サンプルを
回収する滅菌ろ過工程とからなることを特徴とする海洋
生物由来コラーゲンの製造方法。
2. A pre-treatment step of obtaining a treated sample by degreased and washed skin of marine organisms, adding an organic acid to the treated sample to extract collagen, and adding a proteolytic enzyme to atherogenate. Performing an extraction step to extract a crude collagen solution, and removing insolubles from the crude collagen solution to reduce the membrane size to less than 1.0 μm to 0.1 μm.
a purification step of passing through a purification membrane with a microfiltration membrane of μm, and concentrating the purified collagen solution obtained by passing the purified collagen solution through a concentration membrane which is an ultrafiltration membrane having a membrane size of less than 1000K to 10K. A concentration step for removing impurities having a molecular weight fraction or less, and any of the sterilized filtration treatment in which the concentrated collagen solution thus obtained is passed through a filtration sterilization membrane by pressurizing with a dialysis treatment and a sterilization gas. A method for producing marine organism-derived collagen, which comprises a sterile filtration step of collecting a sample after sterile filtration.
【請求項3】 精製工程における精製膜と、濃縮工程に
おける濃縮用膜とが夫々0.2μm〜0.65μm、1
0K〜100Kの膜サイズである請求項1または請求項
2に記載の海洋生物由来コラーゲンの製造方法。
3. The purification membrane in the purification step and the concentration membrane in the concentration step are each 0.2 μm to 0.65 μm,
The method for producing marine organism-derived collagen according to claim 1 or 2, wherein the membrane has a membrane size of 0K to 100K.
【請求項4】 精製工程における精製膜と濃縮工程にお
ける濃縮用膜には、夫々粗コラーゲン溶液と精製コラー
ゲン溶液とが、その流れ方向に対して直交する方向で透
過して行くようにした請求項1ないし請求項3に記載の
海洋生物由来コラーゲンの製造方法。
4. The method according to claim 1, wherein the crude collagen solution and the purified collagen solution permeate through the purification membrane in the purification step and the concentration membrane in the concentration step, respectively, in a direction perpendicular to the flow direction. The method for producing marine organism-derived collagen according to any one of claims 1 to 3.
【請求項5】 海洋生物の皮膚を脱脂した後洗浄して処
理済サンプルを得る前処理工程と、この処理済サンプル
に有機酸を加えてコラーゲンを抽出して得た粗コラーゲ
ン溶液から不溶物を除去して精製膜を通過させることで
精製ろ過し、次いで蛋白質分解酵素を加えてアテロ化を
行うようにした抽出工程と、これにより得られた第1精
製コラーゲン溶液を精製膜に通過させる精製工程と、こ
れにより得られた第2精製コラーゲン溶液を濃縮用膜に
通過させることにより濃縮して、分子量分画以下の不純
物を除去するようにした濃縮工程と、これにより得られ
た濃縮コラーゲン溶液を、透析処理と滅菌ガスにより加
圧することでろ過滅菌膜を通過させる滅菌ろ過処理の何
れかを先行することにより滅菌ろ過後サンプルを回収す
る滅菌ろ過工程とからなることを特徴とする海洋生物由
来コラーゲンの製造方法。
5. A pre-treatment step for obtaining a treated sample by degreased skin of a marine organism and then washing it, and removing an insoluble matter from a crude collagen solution obtained by adding an organic acid to the treated sample to extract collagen. An extraction step of removing and passing through a purification membrane for purification and filtration, and then adding a protease to carry out atherolation, and a purification step of passing the first purified collagen solution obtained through the purification membrane. And a concentration step of concentrating the second purified collagen solution thus obtained by passing it through a membrane for concentration to remove impurities having a molecular weight fraction or less. A sterilization filtration step of collecting a sample after sterilization filtration by preceding any of a dialysis treatment and a sterilization filtration treatment of passing through a filtration sterilization membrane by pressurizing with a sterilizing gas. A method for producing collagen derived from marine organisms.
【請求項6】 海洋生物の皮膚を脱脂した後洗浄して処
理済サンプルを得る前処理工程と、この処理済サンプル
に有機酸を加えてコラーゲンを抽出して得た粗コラーゲ
ン溶液から不溶物を除去して膜サイズが1.0μm未満
〜0.1μmである精密ろ過膜による精製膜を通過させ
ることで精製ろ過し、次いで蛋白質分解酵素を加えてア
テロ化を行うようにした抽出工程と、これにより得られ
た第1精製コラーゲン溶液を同上膜サイズの精密ろ過膜
による精製膜に通過させる精製工程と、これにより得ら
れた第2精製コラーゲン溶液を膜サイズが1000K未
満〜10Kの限外ろ過膜である濃縮用膜に通過させるこ
とにより濃縮して、分子量分画以下の不純物を除去する
ようにした濃縮工程と、これにより得られた濃縮コラー
ゲン溶液を、透析処理と滅菌ガスにより加圧することで
ろ過滅菌膜を通過させる滅菌ろ過処理の何れかを先行す
ることにより、滅菌ろ過後サンプルを回収する滅菌ろ過
工程とからなることを特徴とする海洋生物由来コラーゲ
ンの製造方法。
6. A pretreatment step of obtaining a treated sample by degreased and washed skin of a marine organism, and removing an insoluble substance from a crude collagen solution obtained by adding an organic acid to the treated sample to extract collagen. An extraction step of removing and filtering by passing through a purification membrane with a microfiltration membrane having a membrane size of less than 1.0 μm to 0.1 μm, and then adding at least a protease to carry out atherolation; A purification step in which the first purified collagen solution obtained by the above is passed through a purification membrane using a microfiltration membrane having the same membrane size as described above, and an ultrafiltration membrane having a membrane size of less than 1000 K to 10 K through the second purification collagen solution obtained thereby. A concentration step of removing the impurities having a molecular weight fraction or less by passing through a concentration membrane which is a concentrated collagen solution obtained by the dialysis treatment. And a sterilizing filtration step of collecting a sample after the sterilizing filtration by preceding any of the sterilizing filtration processes of passing through a filtration sterilizing membrane by pressurizing with a sterilizing gas. Method.
【請求項7】 抽出工程および精製ろ過工程における精
製膜と、濃縮工程における濃縮用膜とが夫々0.2μm
〜0.65μm、10K〜100Kの膜サイズである請
求項5または請求項6に記載の海洋生物由来コラーゲン
の製造方法。
7. The purification membrane in the extraction step and the purification filtration step and the concentration membrane in the concentration step each have a size of 0.2 μm.
The method for producing marine organism-derived collagen according to claim 5 or 6, wherein the membrane size is from about 0.65 µm to about 10K to 100K.
【請求項8】 抽出工程における精製膜は、その粗コラ
ーゲン溶液がその流れ方向に対して平行する方向で透過
して行き、精製工程における精製膜と濃縮工程における
濃縮用膜には、夫々粗コラーゲン溶液と第1、第2精製
コラーゲン溶液とが、その流れ方向に対して直交する方
向で透過して行くようにした請求項5ないし請求項7に
記載の海洋生物由来コラーゲンの製造方法。
8. The purified membrane in the extraction step allows the crude collagen solution to permeate in a direction parallel to the flow direction, and the purified membrane in the purification step and the membrane for concentration in the concentration step each contain crude collagen solution. 8. The method for producing marine organism-derived collagen according to claim 5, wherein the solution and the first and second purified collagen solutions pass through in a direction orthogonal to the flow direction.
JP2000014283A 2000-01-24 2000-01-24 Method for producing marine organism-derived collagen Expired - Lifetime JP3532817B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000014283A JP3532817B2 (en) 2000-01-24 2000-01-24 Method for producing marine organism-derived collagen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000014283A JP3532817B2 (en) 2000-01-24 2000-01-24 Method for producing marine organism-derived collagen

Publications (2)

Publication Number Publication Date
JP2001200000A true JP2001200000A (en) 2001-07-24
JP3532817B2 JP3532817B2 (en) 2004-05-31

Family

ID=18541761

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000014283A Expired - Lifetime JP3532817B2 (en) 2000-01-24 2000-01-24 Method for producing marine organism-derived collagen

Country Status (1)

Country Link
JP (1) JP3532817B2 (en)

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003035126A1 (en) * 2001-10-09 2003-05-01 Techno Network Shikoku Co., Ltd. Process for producing biological material, drug, food, medical instrument, cell culture instrument and tissue-inducible material
JP2005095331A (en) * 2003-09-24 2005-04-14 Ihara Suisan Kk Foamed body sheet containing fishskin dermal collagen and its use
KR100492371B1 (en) * 2002-05-01 2005-05-30 주식회사 부원바이오텍 Method for manufacturing mild water-soluble collagen
US6919306B2 (en) 1999-08-09 2005-07-19 Yaizu Suisankagaku Industry Co. Ltd. Method of skin care
WO2005070954A1 (en) * 2004-01-21 2005-08-04 Toray Industries, Inc. Fractionator and method of fractionation
JP2005232156A (en) * 2004-01-21 2005-09-02 Toray Ind Inc Solution of purified component of living body,method for separating the component of the living body and apparatus for separating the component of the living body
JP2007022958A (en) * 2005-07-15 2007-02-01 Katakura Chikkarin Co Ltd Atelocollagen and/or its derivative derived from squid or catfish, method for producing the same, and cosmetic compounded of the atelocollagen and/or its derivative
US7232579B2 (en) 2003-09-17 2007-06-19 Matsumoto Dental University Composition containing a marine-derived inorganic substance and chitin/chitosan, and method of producing the composition
JP2007166989A (en) * 2005-12-22 2007-07-05 Sanki Shiro Kogyo Kk Method for treating bony part of fish
JP2007211053A (en) * 2006-02-07 2007-08-23 Miyagi Prefecture Blue dye, blue collagen or gelatin and method for producing those
JP2008531774A (en) * 2005-02-24 2008-08-14 ローマン ウント ラウシャー ゲーエムベーハー ウント ツェーオー.カーゲー Method for washing marine collagen and treatment for forming a porous sponge thereof
CN102260727A (en) * 2011-06-24 2011-11-30 申铉日 Preparation method of low-molecule aquatic collagen peptide
JP2012206966A (en) * 2011-03-29 2012-10-25 Katakura Chikkarin Co Ltd Collagen originated in marine organism containing iii type collagen, and derivative thereof
JP2013507164A (en) * 2009-10-07 2013-03-04 ケレシス・イーエイチエフ Skeletal material for wound care and / or other tissue healing applications
JP2013245198A (en) * 2012-05-25 2013-12-09 Tokyo Institute Of Technology Method for extracting collagen and method for producing collagen
JP2014105185A (en) * 2012-11-28 2014-06-09 Aomori Prefectural Industrial Technology Research Center Glycine-rich protein
KR101576060B1 (en) * 2013-09-02 2015-12-10 세원셀론텍(주) A High Concentration Collagen and method of preparing
CN105348383A (en) * 2015-12-15 2016-02-24 中国海洋大学 Odourless fishskin collagen and preparation method thereof
JP2016216540A (en) * 2015-05-15 2016-12-22 花王株式会社 Soaking detergent composition for tableware and cleaning method
KR101760890B1 (en) 2016-07-13 2017-07-24 투윈파마 주식회사 Preparing method of Collagen
CN107428800A (en) * 2015-07-08 2017-12-01 中国食品发酵工业研究院 A kind of active peptide for suppressing ampa receptor and its preparation method and application
JP2017216900A (en) * 2016-06-03 2017-12-14 有限会社松下海産 Method for extracting collagen and gelatin
CN110564796A (en) * 2019-07-13 2019-12-13 德州蓝力生物技术有限公司 Production process of hydrolyzed collagen
US11292827B2 (en) 2014-11-21 2022-04-05 Sewoncellontech Co., Ltd. Method for producing high-concentration collagen for using as medical material
CN115028707A (en) * 2022-07-05 2022-09-09 福建爱洁丽日化有限公司 Large yellow croaker skin collagen and preparation method and application thereof

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919306B2 (en) 1999-08-09 2005-07-19 Yaizu Suisankagaku Industry Co. Ltd. Method of skin care
WO2003035126A1 (en) * 2001-10-09 2003-05-01 Techno Network Shikoku Co., Ltd. Process for producing biological material, drug, food, medical instrument, cell culture instrument and tissue-inducible material
KR100492371B1 (en) * 2002-05-01 2005-05-30 주식회사 부원바이오텍 Method for manufacturing mild water-soluble collagen
US7232579B2 (en) 2003-09-17 2007-06-19 Matsumoto Dental University Composition containing a marine-derived inorganic substance and chitin/chitosan, and method of producing the composition
JP2005095331A (en) * 2003-09-24 2005-04-14 Ihara Suisan Kk Foamed body sheet containing fishskin dermal collagen and its use
JP4655938B2 (en) * 2004-01-21 2011-03-23 東レ株式会社 Fractionation apparatus and fractionation method
JP2005232156A (en) * 2004-01-21 2005-09-02 Toray Ind Inc Solution of purified component of living body,method for separating the component of the living body and apparatus for separating the component of the living body
JPWO2005070954A1 (en) * 2004-01-21 2008-01-10 東レ株式会社 Fractionation apparatus and fractionation method
US7795010B2 (en) 2004-01-21 2010-09-14 Toray Industries, Inc. Fractionator and method of fractionation
JP2011006466A (en) * 2004-01-21 2011-01-13 Toray Ind Inc Apparatus and method of fractionation
WO2005070954A1 (en) * 2004-01-21 2005-08-04 Toray Industries, Inc. Fractionator and method of fractionation
JP2008531774A (en) * 2005-02-24 2008-08-14 ローマン ウント ラウシャー ゲーエムベーハー ウント ツェーオー.カーゲー Method for washing marine collagen and treatment for forming a porous sponge thereof
JP2007022958A (en) * 2005-07-15 2007-02-01 Katakura Chikkarin Co Ltd Atelocollagen and/or its derivative derived from squid or catfish, method for producing the same, and cosmetic compounded of the atelocollagen and/or its derivative
JP2007166989A (en) * 2005-12-22 2007-07-05 Sanki Shiro Kogyo Kk Method for treating bony part of fish
JP2007211053A (en) * 2006-02-07 2007-08-23 Miyagi Prefecture Blue dye, blue collagen or gelatin and method for producing those
JP2013507164A (en) * 2009-10-07 2013-03-04 ケレシス・イーエイチエフ Skeletal material for wound care and / or other tissue healing applications
JP2012206966A (en) * 2011-03-29 2012-10-25 Katakura Chikkarin Co Ltd Collagen originated in marine organism containing iii type collagen, and derivative thereof
CN102260727A (en) * 2011-06-24 2011-11-30 申铉日 Preparation method of low-molecule aquatic collagen peptide
JP2013245198A (en) * 2012-05-25 2013-12-09 Tokyo Institute Of Technology Method for extracting collagen and method for producing collagen
JP2014105185A (en) * 2012-11-28 2014-06-09 Aomori Prefectural Industrial Technology Research Center Glycine-rich protein
KR101576060B1 (en) * 2013-09-02 2015-12-10 세원셀론텍(주) A High Concentration Collagen and method of preparing
US11292827B2 (en) 2014-11-21 2022-04-05 Sewoncellontech Co., Ltd. Method for producing high-concentration collagen for using as medical material
JP2016216540A (en) * 2015-05-15 2016-12-22 花王株式会社 Soaking detergent composition for tableware and cleaning method
CN107428800A (en) * 2015-07-08 2017-12-01 中国食品发酵工业研究院 A kind of active peptide for suppressing ampa receptor and its preparation method and application
US10800810B2 (en) 2015-07-08 2020-10-13 China National Research Institute Of Food And Fermentation Industries Active peptide for inhibiting AMPA receptor and preparation method and use thereof
CN107428800B (en) * 2015-07-08 2020-11-27 中国食品发酵工业研究院 Active peptide for inhibiting AMPA receptor and preparation method and application thereof
CN105348383A (en) * 2015-12-15 2016-02-24 中国海洋大学 Odourless fishskin collagen and preparation method thereof
JP2017216900A (en) * 2016-06-03 2017-12-14 有限会社松下海産 Method for extracting collagen and gelatin
KR101760890B1 (en) 2016-07-13 2017-07-24 투윈파마 주식회사 Preparing method of Collagen
CN110564796A (en) * 2019-07-13 2019-12-13 德州蓝力生物技术有限公司 Production process of hydrolyzed collagen
CN115028707A (en) * 2022-07-05 2022-09-09 福建爱洁丽日化有限公司 Large yellow croaker skin collagen and preparation method and application thereof

Also Published As

Publication number Publication date
JP3532817B2 (en) 2004-05-31

Similar Documents

Publication Publication Date Title
JP2001200000A (en) Method for producing collagen derived from marine organism
Porter et al. Utrafiltration in the Chemical, Food Processing, Pharmaceutical, and Medical Industries
KR101645957B1 (en) Process for producing milk fractions rich in secretory immunoglobulins
CN101041486B (en) Method for treatment and comprehensive utilization of silk production waste water
AU2010202280B2 (en) Process for the purification of organic acids
ES2883110T3 (en) Process for the purification of hyaluronic acid
CN102488713B (en) Method for preparing sheep placenta extract and sheep placenta hydrolyzed collagen concentrated solution
JPS60224626A (en) Manufacture of stroma-free, hepatitis-free and high purity human and animal hemoglobin solution
JPH08295697A (en) Production of aqueous solution of silk fibroin at high concentration
KR20190028633A (en) Nano-class collagen refining method with 96% absorption rate
WO2008096074A1 (en) Method for the purification of organic acids
JP3577992B2 (en) Membrane separation method
CN106348429A (en) Kudzuvine root resource utilization method for flavonol, starch and amino acid separation and purification
CN112480243A (en) Large-scale hirudin separation and purification production process method and equipment
CN106966945A (en) A kind of full embrane method extracting method of L hydroxyprolines zymotic fluid
KR101576060B1 (en) A High Concentration Collagen and method of preparing
Bohdziewicz et al. Ultrafiltration preparation of pectinolytic enzymes from citric acid fermentation broth
CN109928566A (en) A kind of animal extracts the processing method and processing device of industrial wastewater
JPH11215980A (en) Treatment of liquid containing microbial cell
Dendukuri et al. Oil-free protein isolates from full-fat, dehulled mustard flour by microfiltration
JP3371783B2 (en) Cell isolation method
CN206089712U (en) Whole blood peptide powder extraction element
CN109810951A (en) A method of the Extraction and enrichment bacteriophage from activated sludge
Conidi et al. Food-processing wastewater treatment by membrane-based operations: recovery of biologically active compounds and water reuse
JP3757076B2 (en) Urea-containing composition derived from milk and method for producing the same

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20031224

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040210

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040304

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 3532817

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080312

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090312

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090312

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100312

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100312

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110312

Year of fee payment: 7

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110312

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120312

Year of fee payment: 8

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120312

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130312

Year of fee payment: 9

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130312

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140312

Year of fee payment: 10

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term